Penumbra (PEN) Net Margin (2014 - 2026)

Penumbra's (PEN) quarterly Net Margin came in at 8.7% in Q1 2026, down 340.0% year-on-year from 3.62% in Q1 2025, and down 29.21% on a QoQ basis from 12.28% in Q4 2025.

Penumbra (PEN) Net Margin (2014 - 2026) Analysis & Trends

Penumbra (PEN) has 13 years of Net Margin data on file, last reported at 8.7% in Q1 2026.

  • On a quarterly basis, Net Margin fell 340.0% year-over-year to 8.7% in Q1 2026; TTM through Mar 2026 was 11.76%, a 836.0% increase from a year earlier, with the FY2025 full-year figure at 12.66%, up 1149.0% from the prior year.
  • Net Margin for Q1 2026 stood at 8.7%, down from 12.28% in the prior quarter.
  • Over the last five years, Net Margin for PEN reached as high as 19.05% in Q4 2023 and fell as low as 20.11% in Q2 2024.
  • Historically, Net Margin has averaged 5.64% across 5 years, with a median of 7.24% in 2023.
  • Across the five-year window, Net Margin tumbled 2735 bps in 2024 and jumped 3345 bps in 2025, its largest moves.
  • Year by year, Net Margin stood at 1.75% in 2022, then surged by 987 bps to 19.05% in 2023, then sank by 44 bps to 10.68% in 2024, then gained by 15 bps to 12.28% in 2025, then fell by 29 bps to 8.7% in 2026.
  • Per Business Quant data, the three most recent Net Margin figures were 8.7% in Q1 2026, 12.28% in Q4 2025, and 12.93% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Abbott Laboratories 181.19 Bn 173.90 Bn 6.27 Bn 9.65%
2 Stryker 128.53 Bn 125.65 Bn 3.81 Bn 12.38%
3 Medtronic 107.77 Bn 98.55 Bn 6.41 Bn 12.84%
4 Boston Scientific 67.72 Bn 66.27 Bn 3.61 Bn 25.77%
5 Edwards Lifesciences 48.21 Bn 44.54 Bn 1.29 Bn -
6 Dexcom 28.41 Bn 27.29 Bn 750.30 Mn 16.74%
7 GE HealthCare Technologies 28.33 Bn 26.05 Bn 1.98 Bn 8.01%
8 Smith & Nephew 26.76 Bn 26.18 Bn - -
9 Koninklijke Philips 25.27 Bn 22.15 Bn 2.07 Bn 3.87%
10 Penumbra 12.54 Bn 11.93 Bn 253.41 Mn 8.70%

Historic Data

Download Data
DateValue
Mar 31, 2026 8.70%
Dec 31, 2025 12.28%
Sep 30, 2025 12.93%
Jun 30, 2025 13.35%
Mar 31, 2025 12.10%
Dec 31, 2024 10.68%
Sep 30, 2024 9.79%
Jun 30, 2024 -20.11%
Mar 31, 2024 3.95%
Dec 31, 2023 19.05%
Sep 30, 2023 3.40%
Jun 30, 2023 7.24%
Mar 31, 2023 3.55%
Dec 31, 2022 1.75%
Sep 30, 2022 -1.06%
Jun 30, 2022 -1.77%
Mar 31, 2022 0.04%
Dec 31, 2021 -12.07%
Sep 30, 2021 4.22%
Jun 30, 2021 4.50%